SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-155782
Filing Date
2020-05-29
Accepted
2020-05-29 16:16:22
Documents
2
Effectiveness Date
2020-05-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d830070ddefa14a.htm DEFA14A 25670
2 GRAPHIC g830070g29b51.jpg GRAPHIC 5437
  Complete submission text file 0001193125-20-155782.txt   34364
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36183 | Film No.: 20928007
SIC: 2836 Biological Products, (No Diagnostic Substances)